Cartesian Therapeutics, Inc. (RNAC) SEC Filings — 2025
17 SEC filings for Cartesian Therapeutics, Inc. (RNAC) in 2025.
Filings
- Cartesian Therapeutics, Inc. 8-K Filing — 8-K · Dec 18, 2025
- Cartesian Therapeutics Files 8-K — 8-K · Nov 13, 2025
- Cartesian's Q3 Loss Widens Amid Soaring R&D, Cash Dwindles — 10-Q · Nov 6, 2025
- Cartesian Therapeutics Files 8-K on Corporate Governance and Compensation — 8-K · Oct 30, 2025
- Cartesian Therapeutics Announces Board and Executive Changes — 8-K · Oct 21, 2025
- Cartesian Therapeutics Reports Board & Executive Changes — 8-K · Oct 8, 2025
- Cartesian's Q2 Losses Widen Amid Increased R&D Spend — 10-Q · Aug 7, 2025
- Cartesian Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 16, 2025
- Cartesian Therapeutics Files 8-K — 8-K · May 30, 2025
- Cartesian Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Cartesian Therapeutics Board and Officer Changes Announced — 8-K · Apr 29, 2025
- Cartesian Therapeutics Files Proxy Statement — DEFA14A · Apr 28, 2025
- Cartesian Therapeutics Files 8-K — 8-K · Apr 8, 2025
- Cartesian Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025
- Cartesian Therapeutics Files 8-K — 8-K · Mar 3, 2025
- Cartesian Therapeutics Files 8-K — 8-K · Jan 27, 2025
- Cartesian Therapeutics Files 8-K — 8-K · Jan 13, 2025